Santen Pharmaceutical Co Ltd
TSE:4536
Santen Pharmaceutical Co Ltd
TSE:4536
Price:
1 569 JPY
-1.81%
Market Closed
Updated:
May 21, 2024
Santen Pharmaceutical Co Ltd
Research & Development
|
Santen Pharmaceutical Co Ltd
Research & Development Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Santen Pharmaceutical Co Ltd
TSE:4536
|
Research & Development
-¥25.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Research & Development
-¥729.9B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-8%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Research & Development
-¥365.2B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-28%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Research & Development
-¥312.2B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-2%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Research & Development
-¥172.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-9%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Research & Development
-¥294.2B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
See Also
What is Santen Pharmaceutical Co Ltd's Research & Development?
Research & Development
-25.4B
JPY
-25.4B
JPY
Based on the financial report for Mar 31, 2024, Santen Pharmaceutical Co Ltd's Research & Development amounts to -25.4B JPY.
What is Santen Pharmaceutical Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-1%
-1%
Over the last year, the Research & Development growth was 10%. The average annual Research & Development growth rates for Santen Pharmaceutical Co Ltd have been -2% over the past three years , -1% over the past five years .
You don't have any saved screeners yet
